Pfizer PFE is due to report third-quarter 2025 results on Nov. 4. All eyes will be on sales of Pfizer’s oncology drugs, which ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

At present, a total of 18 facilities across Slovakia provide vaccination with the new Comirnaty LP.8.1 vaccine. Those ...

Pfizer is expected to report its third-quarter results next month, and analysts are projecting a double-digit decline in its ...

These five stocks of well-run companies yield at least 6% and look like timely buys now as interest rates trend lower.

Health officials say the best way to prevent death or hospitalizations from the flu and other respiratory viruses is to get ...

In a series of questions focusing on the Comirnaty COVID-19 vaccine—developed by pharmaceutical groups BioNTech and Pfizer and the first to be approved in Europe—Hauser asked, "Why did the Commission ...

Pfizer Inc. (NYSE: PFE, "Pfizer") will present data across its infectious disease portfolio at the upcoming IDWeek 2025 congress, held in Atlanta from ...

Americans worried that the U.S. government shutdown could derail their plans to take out a mortgage or refinance their home loan can breathe easy — mostly. Housing experts says lenders will continue ...

Freeze was asked what his message is to fans who question whether or not he and his staff are the right people to lead the program Mobile's Halloween-themed rally drew a large crowd, many who came in ...

Recent storms and cooler weather helped ease Santa Rosa’s fire risk, allowing the city to... Copyright © 2025 MediaNews Group ...